Isodiol International Inc. Announces Sweeping Executive Management Changes

July 27, 2020 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), officially launches the search for a new CFO, following the departure of Eli Dusenberry, legacy executive.

Dear Shareholders,

We like to announce our search for a new permanent CFO, one who is in alignment with the core values of the “New Isodiol.” Legacy Executive, Eli Dusenberry, who served as CFO for 23 months, is no longer with the company and we wish him the best. Dusenberry’s departure is a critical, pivotal move in our restructuring efforts. In the interim, a full-service public accounting and finance consulting firm will assist Isodiol with its financial reporting & analysis, implement processes and procedures to navigate our upcoming fiscal year 2020 audit and continue to reconcile legacy operational accounting practices. “Isodiol stakeholders, we see you; we hear you and we’ve taken swift action regarding your concerns. With the guidance of our new president, Andrew Alvis, we have quickly set new policies and operating procedures, placing Isodiol in position to soar beyond our wildest imaginations. We are extremely confident in our new executive leadership team and know the selection of our new CFO will help take Isodiol to a whole new level in this industry,” said Marcos Agramont, Chief Executive Officer, Isodiol International Inc.

New Policies & Procedures:

Implemented SOP’s to improve timelines for financial reporting
Designed Dual Financial Review & Approvals to drive transparency and control measures to all current and proposed/requested expenditures
Phased in Product Research, Reviews to ensure Isodiol delivers quality, transparent product offerings to our customers
Established Customer Service and Support to provide 5-star service; encouraging customers to prefer Isodiol as theirBrand of Choice  

We will continue to remain focused on Isodiol’s restructuring execution. We will work to attract and retain the best talent for it is critical for the long-term success of Isodiol. We are confident through our current executive search process; we will be able to continue the expansion of our leadership team with proven and successful resources needed to ensure a streamlined restructuring execution for Isodiol. We will take necessary steps to extensively vet all qualified candidates and plan to have our new CFO hired by September 1, 2020,” said Andrew S. Alvis, President, Isodiol International Inc.

We are grateful for your continued trust and support and hope you are staying safe and healthy during these unprecedent times.


Andrew S. Alvis

President & Director, Isodiol International, Inc.

Follow Our Corporate Updates:

Facebook at



About Isodiol International Inc.

Isodiol International Inc. is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing, and distribution company of hemp-based Consumer Packaged Goods (CPG) and solutions. Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nanotechnology for quality consumable and topical skin care products. Isodiol’s growth strategy includes the development of over the counter and pharmaceutical drugs and continued international expansion into Latin America, Asia, and Europe.


Marcos Agramont, CEO & Director

INVESTOR RELATIONS: [email protected]


MEDIA CONTACT: [email protected]

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, its ability to repay the Debentures, and the future of the Company’s business. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release, that the Company may not be able to repay the Debentures in whole or in part, and that the Company may not otherwise be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved, or disapproved the content of this press release.